Volta Clinical Evidence Roadmap

One of the most ambitious clinical programs focused on the underserved complex Atrial Fibrillation (AF) patient
The Problem
Underserved population of Complex AFib Patients

70%

of all AFib patients suffer from complex AF1

<50%

of catheter ablation treatments are persistent AF patients2
Our Approach
Industry-Leading Research Scope and quality
Published
2017
AF Ablation Guided by Spatiotemporal Electrogram Dispersion Whithout Pulmonary Vein Isolation
2022
Ev-AIFib
(The Preliminary Evaluation of the AI-AF Software Trial)
Results announced
2024
The Tailored-AF Trial
Multicenter RCT
READ More about the RESULTS
Ongoing
RESTART Trial
Multicenter Prospective Study for Redo Procedures
READ more about the trial
Clinical Registry
Multicenter Prospective Study